Testing effectiveness (Phase 2)Study completedNCT02833350
What this trial is testing
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 578